Detalles de la búsqueda
1.
When should factorial designs be used for late-phase randomised controlled trials?
Clin Trials
; 21(2): 162-170, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37904490
2.
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
Clin Infect Dis
; 77(9): 1312-1317, 2023 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37280040
3.
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Clin Infect Dis
; 77(6): 875-882, 2023 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315296
4.
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
Clin Infect Dis
; 66(suppl_2): S132-S139, 2018 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29514234
5.
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
PLoS Med
; 15(12): e1002706, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30513108
6.
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
PLoS Med
; 14(11): e1002432, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29136032
7.
Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
J Infect Dis
; 214(2): 226-36, 2016 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27190179
8.
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
Br J Haematol
; 166(1): 109-17, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24673708
9.
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.
Blood
; 119(1): 7-15, 2012 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22021371
10.
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.
Blood
; 118(5): 1231-8, 2011 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21652683
11.
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.
Haematologica
; 97(3): 442-50, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22058209
12.
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.
EClinicalMedicine
; 44: 101262, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043093
13.
Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen.
Haematologica
; 101(2): e69-71, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26471484
14.
The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.
AIDS
; 35(10): 1537-1548, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34270487
15.
Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe.
AIDS
; 33(9): 1485-1490, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31008797
16.
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.
Sci Transl Med
; 11(486)2019 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30944164
17.
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.
Lancet HIV
; 5(5): e231-e240, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653915
18.
Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.
Pediatr Infect Dis J
; 36(6): 588-594, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28505015
19.
Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
AIDS
; 29(5): 609-18, 2015 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25710288
20.
Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
Pediatr Infect Dis J
; 34(2): e23-31, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25068287